PMID: 29782282May 22, 2018Paper

Cell therapy of chronic heart failure: State of the art

Kardiologiia
S A Beliy, V V Komok

Abstract

The treatment of patients with CHF using autologous bone marrow-derived mononuclear cell fraction (or its derivatives) is a promising therapy for this serious and numerous group of patients. The article analyzed international and Russian experience of using the cell therapy in patients with CHF and possibilities for extensive use of the autologous bone marrow-derived mononuclear cell fraction in clinical practice.

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.